Abstract: Provided according to embodiments of the invention pharmaceutical capsules that include a capsule body and a capsule cap, wherein the capsule cap envelops an open end of the capsule body to form a capsule core; and an adherence sheath that envelops a portion of the capsule core. Related capsules and methods of making such capsules are also provided herein.

Abstract: Provided is a method for preparing a needle-like sulfide-based solid electrolyte. The method may include: preparing a solid electrolyte admixture comprising an organic solvent, Li2S, P2S5, and LiCl; synthesizing a solid electrolyte by stirring the solid electrolyte admixture at a temperature of about 30 to 60° C. for about 22 to 26 hours; first stirring the solid electrolyte at a speed of about 80 to 120 rpm for about 5 to 10 minutes; after the first stirring, second stirring the first stirred solid electrolyte at a speed of about 250 to 300 rpm; vacuum-drying the second stirred solid electrolyte for about 12 to 24 hours; and heat-treating the vacuum-dried solid electrolyte at a temperature of about 350 to 550° C. for about 1 to 5 hours.

Abstract: A system and method for analysis of 3D deformations and regional function of a heart includes: a magnetic resonance imaging (MRI) scanner configured to acquire three tagged volume data series with mutually perpendicular tag lines of a heart; a data storage device in communication with the MRI scanner and configured to store the three tagged volume data series; and an image processing machine in communication with data storage device. The image processing machine is configured to: model an intensity distribution around each voxel of each tagged volume data series as a moving sine wave front with a local frequency and an amplitude; and determine a phase and frequency for each voxel from the local frequency and amplitude and a displacement from a quotient of a phase difference and the local frequency.

Abstract: The method for shuffled decoding of LDPC codes includes calculating check-variable mutual information which is mutual information of a message propagating from a plurality of check nodes to a plurality of variable nodes by a check-variable mutual information calculating unit, calculating variable-check mutual information which is mutual information of a message propagating from the plurality of variable nodes to the plurality of check nodes connected to the plurality of variable nodes based on the check-variable mutual information by a variable-check mutual information calculating unit, and Calculating the entire mutual information which is a sum of variable-check mutual information for each of the plurality of variable nodes and determines an operation order of a variable node having the largest entire mutual information among the plurality of variable nodes to be next, by an operation order determining unit.

Abstract: Disclosed are a memory management system and a method thereof. Restricted spare cells are optimally distributed (or allocated) into a physical region and a virtual region in a system for repairing a fault of a memory, thereby increasing a yield of a memory chip.

Abstract: The invention generally relates to apparatuses for focusing ions at or above ambient pressure and methods of use thereof. In certain embodiments, the invention provides an apparatus for focusing ions that includes an electrode having a cavity, at least one inlet within the electrode configured to operatively couple with an ionization source, such that discharge generated by the ionization source is injected into the cavity of the electrode, and an outlet. The cavity in the electrode is shaped such that upon application of voltage to the electrode, ions within the cavity are focused and directed to the outlet, which is positioned such that a proximal end of the outlet receives the focused ions and a distal end of the outlet is open to ambient pressure.

Abstract: The invention generally relates to systems and methods for quantifying an analyte extracted from a sample. In certain embodiments, the invention provides methods that involve introducing a solvent into a capillary, introducing the capillary into a vessel including a sample such that a portion of the sample is introduced into the capillary, moving the sample and the solvent within the capillary to induce circulation within the sample and the solvent, thereby causing the analyte to be extracted from the sample and into the solvent, analyzing the analyte that has been extracted from the sample, and quantifying the analyte. In certain embodiments, the quantifying step is performed without knowledge of a volume of the sample and/or solvent.

Abstract: A method for naming a Domain Name System (DNS) for an Internet of Things (IoT) device comprises the steps of: receiving a first message including a DNS search list by a device connected to a network on the basis of Internet Protocol Version 6 (IPv6) protocol; generating, by the device, a domain name including model information and an identifier of the device; performing, by the device, a redundancy check for the domain name on the basis of a neighbor discovery (ND) protocol; and, when the domain name is not redundant, registering the domain name and IPv6 address for the device into a DNS server on the basis of a node information (NI) protocol by a domain name-collecting apparatus connected to the network.

Abstract: Compositions and methods are provided for treating a patient suffering from a disease associated with endothelial dysfunction by administering to the patient a pharmaceutical composition containing an effective amount of a synthetic collagen binding peptidoglycan.

Abstract: The presently-disclosed subject matter includes isolated polypeptides that comprise a butyrylcholinestrase (BChE) polypeptide and a second polypeptide. The BChE polypeptide as well as the second polypeptide can be variants and/or fragments thereof. The presently-disclosed subject matter also includes a pharmaceutical composition that comprises the present isolated polypeptide and a suitable pharmaceutical carrier. Further still, methods are provided for treating cocaine-induced conditions, and comprise administering the isolated polypeptide and/or pharmaceutical compositions thereof to an individual.

Abstract: The present invention relates to a respiratory tubing set for controlling breathing of a patient. A tubing set for controlling breathing of a patient includes a respiratory conduit. The respiratory conduit is configured to be coupled to a patient interface device and is further configured to be coupled to a pressurized air generating device. The respiratory conduit includes at least two airflow control devices, positioned between the patient interface device and the pressurized air generating device that cooperate to closely control the CO2 levels in the patient's bloodstream through the control of the patient's respiration.

Abstract: This document provides methods and materials involved in identifying and/or treating acute GVHD. For example, methods and materials for detecting elevated levels of nucleic acid expression (e.g., an elevated level of MxA nucleic acid expression or an elevated level of expression of a nucleic acid that encodes a polypeptide listed in Table 2, Table 3, and/or Table 4) in a skin sample to identify a mammal as having acute GVHD are provided.

Abstract: The invention provides chemical compounds for binding to a liquid phase cation having the formula R1—SO2—S—R2—SH, wherein R1 comprises a support molecule, such as a polymer, and R2 comprises an alkyl. The polymer may be a crosslinked, polystyrene divinylbenzene copolymer having a plurality of pendant benzyl groups to which the —SO2—S—R2—SH ligand is attached. The alkyl group may be ethyl or propyl. The chemical compound may be used to complex cation lead or mercury, in which the cation is complexed with mercapto-sulfur of the thio-sulfonyl moiety and the terminal mercaptan to form a heterocyclic ring-like geometry incorporating the cation. A method for removing cations from a liquid stream using the chemical compounds of the present invention is also provided.

Abstract: A nerve repair conduit configured to be secured on first and second portions of a selected nerve. The nerve repair conduit includes a polymeric body having a proximal end, a distal end, an exterior surface and an interior surface defining an interior lumen. In addition, the nerve conduit includes at least one drug reservoir to hold agent(s) that may, for example, facilitate nerve regeneration. The drugs diffuse from the drug reservoir(s) into the nerve repair conduit through an outlet (e.g., a semipermeable membrane) in proximity to the first and second portions of a selected nerve. The nerve repair conduit may be configured to deliver the agent(s) at a rate having substantially zero-order kinetics and/or at a constant rate over a selected period of time (e.g., at least 1 week).

Abstract: A protocol model generator according to the present disclosure includes: a memory in which a protocol model generating program is stored; and a processor configured to execute the program. Herein, upon execution of the program, the processor extracts multiple strings from a binary corresponding to a protocol, generates a message pool including multiple candidate messages to be used in the protocol corresponding to the binary on the basis of the extracted multiple strings, and generates a protocol model corresponding to the protocol and configured to include nodes corresponding to the respective candidate messages included in the message pool. Further, the candidate messages include messages generated on the basis of the strings and response messages generated corresponding to the messages, and the protocol model is generated including one or more nodes and transition information between the nodes.

Abstract: A method for manufacturing a semiconductor device with an improved doping profile is provided. The method includes providing a measuring target including a first region having a plurality of layers, inputting a first input signal into the measuring target and measuring a resulting first output signal, such as a change over time of a first output electric field that is transmitted through or reflected by the first region. Based on a first model including first structural information of a plurality of first modeling layers and information on doping concentrations of each of the plurality of first modeling layers, calculating a second output signal. When a result of comparing the first output signal with the second output signal is smaller than a threshold value, a three-dimensional model of the measuring target may be estimated based on the first model.

Abstract: A method of manufacturing a thin film transistor substrate may include forming a gate electrode on a base substrate, forming a gate insulation layer on the base substrate, the gate insulation layer covering the gate electrode, performing a simultaneous ultraviolet ray irradiation and thermal treatment (SUT) process by irradiating an ultraviolet ray at the gate insulation layer and supplying heat to the gate insulation layer at substantially the same time, forming an active pattern on the gate insulation layer, the active pattern overlapping the gate electrode, and forming a source electrode and a drain electrode on the gate insulation layer, the source electrode and the drain electrode being electrically connected to the active pattern.

Abstract: Disclosed herein is a shape memory alloy comprising 45 to 50 atomic percent nickel; and 1 to 30 atomic percent of at least one metalloid selected from the group consisting of germanium, antimony, zinc, gallium, tin, and a combination of one or more of the foregoing metalloids, with the remainder being titanium. The shape memory alloy may further contain aluminum. Disclosed herein too is a method of manufacturing the shape memory alloy.

Abstract: The invention pertains to a plant cell or a plant having one or more mutations in the promoters of both the alleles for CsLOB1 gene, wherein the one or more mutations are in the promoter binding sites for PthA4 protein from Xanthomonas spp., and wherein the one or more mutations reduce or abolish the binding of the Xanthomonas spp. PthA4 protein on to the binding sites in the promoters of the CsLOB1 genes. Also, a plant cell or a plant having one or more mutations in the coding regions of both the alleles for CsLOB1 gene, wherein the one or more mutations reduce or abolish the binding of the function of CsLOB1 protein are provided. The invention further pertains to the methods of making the plant cell or the plant resistant to infection by Xanthomonas spp.

Abstract: ‘MAGNUS’ is a new and distinct southern highbush blueberry (Vaccinium corymbosum L.) variety distinguished at least by a low chilling requirement, upright growth habit, good field disease resistance, and large, firm fruit that are sweet with small, dry picking scars.